Role of Brain-Derived Neurotrophic Factor in Beneficial Effects of Repetitive Transcranial Magnetic Stimulation for Upper Limb Hemiparesis after Stroke.
Aged; Arm; Brain-Derived Neurotrophic Factor/blood/genetics/physiology; Case-Control Studies; Female; Humans; Male; Matrix Metalloproteinase 9/blood; Middle Aged; Paresis/etiology/physiopathology/rehabilitation/therapy; Polymorphism, Genetic/genetics/physiology; Protein Precursors/blood; Stroke/complications; Transcranial Direct Current Stimulation
Abstract :
[en] BACKGROUND: Repetitive transcranial magnetic stimulation (rTMS) can improve upper limb hemiparesis after stroke but the mechanism underlying its efficacy remains elusive. rTMS seems to alter brain-derived neurotrophic factor (BDNF) and such effect is influenced by BDNF gene polymorphism. OBJECTIVES: To investigate the molecular effects of rTMS on serum levels of BDNF, its precursor proBDNF and matrix metalloproteinase-9 (MMP-9) in poststroke patients with upper limb hemiparesis. METHODS: Poststroke patients with upper limb hemiparesis were studied. Sixty-two patients underwent rehabilitation plus rTMS combination therapy and 33 patients underwent rehabilitation monotherapy without rTMS for 14 days at our hospital. One Hz rTMS was applied over the motor representation of the first dorsal interosseous muscle on the non-lesional hemisphere. Fugl-Meyer Assessment and Wolf Motor Function (WMFT) were used to evaluate motor function on the affected upper limb before and after intervention. Blood samples were collected for analysis of BDNF polymorphism and measurement of BDNF, proBDNF and MMP-9 levels. RESULTS: Two-week combination therapy increased BDNF and MMP-9 serum levels, but not serum proBDNF. Serum BDNF and MMP-9 levels did not correlate with motor function improvement, though baseline serum proBDNF levels correlated negatively and significantly with improvement in WMFT (rho = -0.422, p = 0.002). The outcome of rTMS therapy was not altered by BDNF gene polymorphism. CONCLUSIONS: The combination therapy of rehabilitation plus low-frequency rTMS seems to improve motor function in the affected limb, by activating BDNF processing. BDNF and its precursor proBDNF could be potentially suitable biomarkers for poststroke motor recovery.
Disciplines :
Neurology
Author, co-author :
Niimi, Masachika ; Université de Liège - ULiège > Consciousness-Coma Science Group
Hashimoto, Kenji
Kakuda, Wataru
Miyano, Satoshi
Momosaki, Ryo
Ishima, Tamaki
Abo, Masahiro
Language :
English
Title :
Role of Brain-Derived Neurotrophic Factor in Beneficial Effects of Repetitive Transcranial Magnetic Stimulation for Upper Limb Hemiparesis after Stroke.
Publication date :
2016
Journal title :
PLoS ONE
eISSN :
1932-6203
Publisher :
Public Library of Science, United States - California
Lefaucheur JP, André-Obadia N, Antal A, Ayache SS, Baeken C, Benninger DH, et al. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS). Clin Neurophysiol. 2014;125:2150-2206. doi: 10.1016/j.clinph.2014.05.021 PMID: 25034472
Lüdemann-Podubecká J, Bösl K, Nowak DA. Repetitive transcranial magnetic stimulation for motor recovery of the upper limb after stroke. Prog Brain Res. 2015;218:281-311. doi: 10.1016/bs.pbr.2014. 12.001 PMID: 25890143
Müller-Dahlhaus F, Vlachos A. Unraveling the cellular and molecular mechanisms of repetitive magnetic stimulation. Front Mol Neurosci. 2013;6:50. doi: 10.3389/fnmol.2013.00050 PMID: 24381540
Nestler EJ, Barrot M, Di Leone RJ, Eisch AJ, Gold SJ, Monteggia LM. Neurobiology of depression. Neuron. 2002;34:13-25. PMID: 11931738
Hashimoto K, Shimizu E, Iyo M. Critical role of brain-derived neurotrophic factor in mood disorders. Brain Res Brain Res Rev. 2004;45:104-114. PMID: 15145621
Duman RS, Monteggia LM. A neurotrophic model for stress-related mood disorders. Biol Psychiatry. 2006;59:1116-1127. PMID: 16631126
Hashimoto K. Brain-derived neurotrophic factor as a biomarker for mood disorders: an historical overview and future directions. Psychiatry Clin Neurosci. 2010;64:341-357. doi: 10.1111/j.1440-1819. 2010.02113.x PMID: 20653908
Hashimoto K. Sigma-1 receptor chaperone and brain-derived neurotrophic factor: emerging links between cardiovascular disease and depression. Prog Neurobiol. 2013;100:15-29. doi: 10.1016/j. pneurobio.2012.09.001 PMID: 23044468
Castrén E. Neurotrophins and psychiatric disorders. Handb Exp Pharmacol. 2014;220:461-479. doi: 10.1007/978-3-642-45106-5-17 PMID: 24668483
Yukimasa T, Yoshimura R, Tamagawa A, Uozumi T, Shinkai K, Ueda N, et al. High-frequency repetitive transcranial magnetic stimulation improves refractory depression by influencing catecholamine and brain-derived neurotrophic factors. Pharmacopsychiatry. 2006;39:52-59. PMID: 16555165
Zanardini R, Gazzoli A, Ventriglia M, Perez J, Bignotti S, Rossini PM, et al. Effect of repetitive transcranial magnetic stimulation on serum brain derived neurotrophic factor in drug resistant depressed patients. J Affect Disord. 2006;91:83-86. PMID: 16448701
Wang HY, Crupi D, Liu J, Stucky A, Cruciata G, Di Rocco A, et al. Repetitive transcranial magnetic stimulation enhances BDNF-TrkB signaling in both brain and lymphocyte. J Neurosci. 2011;31:11044-11054. doi: 10.1523/JNEUROSCI.2125-11.2011 PMID: 21795553
Chang WH, Bang OY, Shin YI, Lee A, Pascual-Leone A, Kim YH. BDNF polymorphism and differential rTMS effects on motor recovery of stroke patients. Brain Stimul. 2014;7:553-558. doi: 10.1016/j.brs. 2014.03.008 PMID: 24767962
Lu B, Pang PT, Woo NH. The yin and yang of neurotrophin action. Nat Rev Neurosci. 2005;6:603-614. PMID: 16062169
Yoshida T, Ishikawa M, Iyo M, Hashimoto K. Serum levels of mature brain-derived neurotrophic factor (BDNF) and its precursor proBDNF in healthy subjects. Open Clin Chem J. 2012;5:7-12.
Hashimoto K. Serum brain-derived neurotrophic factor as a predictor of incident dementia. JAMA Neurol. 2014;71:653.
Hashimoto K. BDNF and proBDNF as biomarkers for bipolar disorder. Br J Psychiatry. 2014;205:410.
Hashimoto K. Brain-derived neurotrophic factor (BDNF) and its precursor proBDNF as diagnostic biomarkers for major depressive disorder and bipolar disorder. Eur Arch Psychiatry Clin Neurosci. 2015;265:83-84. doi: 10.1007/s00406-014-0557-x PMID: 25362578
Yoshida T, Ishikawa M, Niitsu T, Nakazato M, Watanabe H, Shiraishi T, et al. Decreased serum levels of mature brain-derived neurotrophic factor (BDNF), but not its precursor proBDNF, in patients with major depressive disorder. PLoS One. 2012;7:e42676. doi: 10.1371/journal.pone.0042676 PMID: 22880079
Maeda F, Keenan JP, Tormos JM, Topka H, Pascual-Leone A. Modulation of corticospinal excitability by repetitive transcranial magnetic stimulation. Clin Neurophysiol. 2000;111:800-805. PMID: 10802449
Pascual-Leone A, Amedi A, Fregni F, Merabet LB. The plastic human brain cortex. Annu Rev Neurosci. 2005;28:377-401. PMID: 16022601
Ward NS, Cohen LG. Mechanisms underlying recovery of motor function after stroke. Arch Neurol. 2004;61:1844-1848. PMID: 15596603
Takeuchi N, Chuma T, Matsuo Y, Watanabe I, Ikoma K. Repetitive transcranial magnetic stimulation of contralesional primary motor cortex improves hand function after stroke. Stroke. 2005;36:2681-2686. PMID: 16254224
Villardita C. Raven's colored Progressive Matrices and intellectual impairment in patients with focal brain damage. Cortex. 1985;21:627-634. PMID: 2419033
Fugl-Meyer AR, Jääskö L, Leyman I, Olsson S, Steglind S. The post-stroke hemiplegic patient. 1. a method for evaluation of physical performance. Scand J Rehabil Med. 1975;7:13-31. PMID: 1135616
Wolf SL, Catlin PA, Ellis M, Archer AL, Morgan B, Piacentino A. Assessing Wolf motor function test as outcome measure for research in patients after stroke. Stroke. 2001;32:1635-1639. PMID: 11441212
Itoh K, Hashimoto K, Kumakiri C, Shimizu E, Iyo M. Association between brain-derived neurotrophic factor 196 G/A polymorphism and personality traits in healthy subjects. Am J Med Genet B Neuropsychiatr Genet. 2004;124B: 61-63. PMID: 14681916
Itoh K, Hashimoto K, Shimizu E, Sekine Y, Ozaki N, Inada T, et al. Association study between brainderived neurotrophic factor gene polymorphisms and methamphetamine abusers in Japan. Am J Med Genet B Neuropsychiatr Genet. 2005;132B: 70-73. PMID: 15459944
Abo M, Kakuda W, Momosaki R, Harashima H, Kojima M, Watanabe S, et al. Randomized, multicenter, comparative study of NEURO versus CIMT in poststroke patients with upper limb hemiparesis: the NEURO-VERIFY Study. Int J Stroke. 2014;9:607-612. doi: 10.1111/ijs.12100 PMID: 24015934
Mirowska-Guzel D, Gromadzka G, Seniow J, Lesniak M, Bilik M, Waldowski K, et al. Association between BDNF-196 G>A and BDNF-270 C>T polymorphisms, BDNF concentration, and rTMS-supported long-term rehabilitation outcome after ischemic stroke. NeuroRehabilitation. 2013;32:573-582. doi: 10.3233/NRE-130879 PMID: 23648611
Cheeran B, Talelli P, Mori F, Koch G, Suppa A, Edwards M, et al. A common polymorphism in the brainderived neurotrophic factor gene (BDNF) modulates human cortical plasticity and the response to rTMS. J Physiol. 2008;586:5717-5725. doi: 10.1113/jphysiol.2008.159905 PMID: 18845611
Södersten K, Pålsson E, Ishima T, Funa K, Landén M, Hashimoto K, et al. Abnormality in serum levels of mature brain-derived neurotrophic factor (BDNF) and its precursor proBDNF in mood-stabilized patients with bipolar disorder: a study of two independent cohorts. J Affect Disord. 2014;160:1-9. doi: 10.1016/j.jad.2014.01.009 PMID: 24709015
Levin R, Dor-Abarbanel AE, Edelman S, Durrant AR, Hashimoto K, Javitt DC, et al. Behavioral and cognitive effects of the N-methyl-D-aspartate receptor co-agonist D-serine in healthy humans: initial findings. J Psychiatr Res. 2015;61:188-195. doi: 10.1016/j.jpsychires.2014.12.007 PMID: 25554623
